This review summarizes 15 years of research on Semax, a nootropic ACTH(4-10) analog. The comprehensive overview covers the peptide's design, mechanism of action, neuroprotective properties, and clinical applications in cerebrovascular and neurodegenerative conditions.
Asmarin, I P; Nezavibat'ko, V N; Miasoedov, N F; Kamenskiĭ, A A; Grivennikov, I A; Ponomareva-Stepnaia, M A; Andreeva, L A; Kaplan, A Ia; Koshelev, V B; Riasina, T V